Amir Englund
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Toxicology top 1%
- Forensic Toxicology and Drug Analysis
Papers in
- Pharmacology 23
- Cannabis and Cannabinoid Research 23
-
- Schizophrenia research and treatment 8
- Bipolar Disorder and Treatment 6
- Co-authors
- Robin Murray (9 shared papers)Philip McGuire (10 shared papers)Tom P. Freeman (10 shared papers)Marta Di Forti (2 shared papers)Edward Chesney (10 shared papers)Paul D. Morrison (3 shared papers)Harriet Quigley (1 shared paper)Diego Quattrone (1 shared paper)
- Journals
- Journal of Psychopharmacology (6 papers)Neuropsychopharmacology (3 papers)Addiction (3 papers)Neuroscience & Biobehavioral Reviews (2 papers)Cannabis and Cannabinoid Research (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Amir Englund
27 papers receiving 1.4k citations
Amir Englund's Hit Papers
Peers
Comparison fields: 5 of 76
- Pharmacology 1.2k
- Toxicology 166
- Psychiatry and Mental health 311
- Cellular and Molecular Neuroscience 366
- Biological Psychiatry 48
Countries citing papers authored by Amir Englund
This map shows the geographic impact of Amir Englund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Englund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Englund more than expected).
Fields of papers citing papers by Amir Englund
This network shows the impact of papers produced by Amir Englund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Englund. The network helps show where Amir Englund may publish in the future.
Co-authors
The 25 scholars most cited alongside Amir Englund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment Hit paper breakdown → | 2012 | 361 |
| 2 | 2020 | 175 | |
| 3 | 2016 | 161 | |
| 4 | 2017 | 123 | |
| 5 | 2017 | 107 | |
| 6 | 2015 | 74 | |
| 7 | 2022 | 69 | |
| 8 | 2020 | 65 | |
| 9 | 2017 | 47 | |
| 10 | 2019 | 30 | |
| 11 | 2014 | 26 | |
| 12 | 2021 | 25 | |
| 13 | 2023 | 24 | |
| 14 | 2020 | 24 | |
| 15 | 2020 | 17 | |
| 16 | 1990 | 16 | |
| 17 | 2012 | 15 | |
| 18 | 2022 | 13 | |
| 19 | 2024 | 10 | |
| 20 | 2022 | 9 |
About Amir Englund
Amir Englund is a scholar working on Pharmacology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Clinical Psychology and Endocrine and Autonomic Systems, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (23 papers), Schizophrenia research and treatment (8 papers), Bipolar Disorder and Treatment (6 papers), Neuroscience of respiration and sleep (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Psychedelics and Drug Studies (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). The work is most often cited by research in Pharmacology (1.2k citations), Toxicology (166 citations), Psychiatry and Mental health (311 citations), Cellular and Molecular Neuroscience (366 citations) and Biological Psychiatry (48 citations). Amir Englund has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Robin Murray, Philip McGuire, Tom P. Freeman, Marta Di Forti, Edward Chesney, Paul D. Morrison, Harriet Quigley, Diego Quattrone, James Stone and Dominic Oliver. Their work appears in journals such as Journal of Psychopharmacology, Neuropsychopharmacology, Addiction, Neuroscience & Biobehavioral Reviews and Cannabis and Cannabinoid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.